153 related articles for article (PubMed ID: 37717042)
1. DrugMechDB: A Curated Database of Drug Mechanisms.
Gonzalez-Cavazos AC; Tanska A; Mayers M; Carvalho-Silva D; Sridharan B; Rewers PA; Sankarlal U; Jagannathan L; Su AI
Sci Data; 2023 Sep; 10(1):632. PubMed ID: 37717042
[TBL] [Abstract][Full Text] [Related]
2. DrugMechDB: A Curated Database of Drug Mechanisms.
Gonzalez-Cavazos AC; Tanska A; Mayers MD; Carvalho-Silva D; Sridharan B; Rewers PA; Sankarlal U; Jagannathan L; Su AI
bioRxiv; 2023 May; ():. PubMed ID: 37205439
[TBL] [Abstract][Full Text] [Related]
3. Design and application of a knowledge network for automatic prioritization of drug mechanisms.
Mayers M; Tu R; Steinecke D; Li TS; Queralt-Rosinach N; Su AI
Bioinformatics; 2022 May; 38(10):2880-2891. PubMed ID: 35561182
[TBL] [Abstract][Full Text] [Related]
4. Exploiting semantic patterns over biomedical knowledge graphs for predicting treatment and causative relations.
Bakal G; Talari P; Kakani EV; Kavuluru R
J Biomed Inform; 2018 Jun; 82():189-199. PubMed ID: 29763706
[TBL] [Abstract][Full Text] [Related]
5. REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction.
Gu Y; Zheng S; Yin Q; Jiang R; Li J
Comput Biol Med; 2022 Nov; 150():106127. PubMed ID: 36182762
[TBL] [Abstract][Full Text] [Related]
6. Non-Negative Matrix Factorization for Drug Repositioning: Experiments with the repoDB Dataset.
Bakal G; Kilicoglu H; Kavuluru R
AMIA Annu Symp Proc; 2019; 2019():238-247. PubMed ID: 32308816
[TBL] [Abstract][Full Text] [Related]
7. Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning.
Shameer K; Glicksberg BS; Hodos R; Johnson KW; Badgeley MA; Readhead B; Tomlinson MS; O'Connor T; Miotto R; Kidd BA; Chen R; Ma'ayan A; Dudley JT
Brief Bioinform; 2018 Jul; 19(4):656-678. PubMed ID: 28200013
[TBL] [Abstract][Full Text] [Related]
8. Drug prioritization using the semantic properties of a knowledge graph.
Malas TB; Vlietstra WJ; Kudrin R; Starikov S; Charrout M; Roos M; Peters DJM; Kors JA; Vos R; 't Hoen PAC; van Mulligen EM; Hettne KM
Sci Rep; 2019 Apr; 9(1):6281. PubMed ID: 31000794
[TBL] [Abstract][Full Text] [Related]
9. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
10. Knowledge-driven drug repurposing using a comprehensive drug knowledge graph.
Zhu Y; Che C; Jin B; Zhang N; Su C; Wang F
Health Informatics J; 2020 Dec; 26(4):2737-2750. PubMed ID: 32674665
[TBL] [Abstract][Full Text] [Related]
11. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
12. A framework for the targeted selection of herbs with similar efficacy by exploiting drug repositioning technique and curated biomedical knowledge.
Yea SJ; Kim BY; Kim C; Yi MY
J Ethnopharmacol; 2017 Aug; 208():117-128. PubMed ID: 28687508
[TBL] [Abstract][Full Text] [Related]
13. Drug repositioning based on the heterogeneous information fusion graph convolutional network.
Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011
[TBL] [Abstract][Full Text] [Related]
14. A Review of Recent Developments and Progress in Computational Drug Repositioning.
Shi W; Chen X; Deng L
Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
[TBL] [Abstract][Full Text] [Related]
15. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605
[TBL] [Abstract][Full Text] [Related]
16. In silico drug repositioning based on integrated drug targets and canonical correlation analysis.
Chen H; Zhang Z; Zhang J
BMC Med Genomics; 2022 Mar; 15(1):48. PubMed ID: 35249529
[TBL] [Abstract][Full Text] [Related]
17. iDrug: Integration of drug repositioning and drug-target prediction via cross-network embedding.
Chen H; Cheng F; Li J
PLoS Comput Biol; 2020 Jul; 16(7):e1008040. PubMed ID: 32667925
[TBL] [Abstract][Full Text] [Related]
18. Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph-Based Approach.
Lou P; Fang A; Zhao W; Yao K; Yang Y; Hu J
J Med Internet Res; 2023 Oct; 25():e45225. PubMed ID: 37862061
[TBL] [Abstract][Full Text] [Related]
19. Dr AFC: drug repositioning through anti-fibrosis characteristic.
Wu D; Gao W; Li X; Tian C; Jiao N; Fang S; Xiao J; Xu Z; Zhu L; Zhang G; Zhu R
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32572450
[TBL] [Abstract][Full Text] [Related]
20. Knowledge graphs and their applications in drug discovery.
MacLean F
Expert Opin Drug Discov; 2021 Sep; 16(9):1057-1069. PubMed ID: 33843398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
